Compare OBIO & RFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OBIO | RFI |
|---|---|---|
| Founded | 2017 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 253.9M | 293.3M |
| IPO Year | 2020 | N/A |
| Metric | OBIO | RFI |
|---|---|---|
| Price | $6.35 | $10.41 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $12.14 | N/A |
| AVG Volume (30 Days) | ★ 323.2K | 88.4K |
| Earning Date | 11-09-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.25% |
| EPS Growth | ★ 33.13 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $33,482,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $33.03 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 1169.22 | N/A |
| 52 Week Low | $2.66 | $10.37 |
| 52 Week High | $6.50 | $12.07 |
| Indicator | OBIO | RFI |
|---|---|---|
| Relative Strength Index (RSI) | 64.86 | 27.20 |
| Support Level | $3.80 | N/A |
| Resistance Level | $6.48 | $11.24 |
| Average True Range (ATR) | 0.33 | 0.13 |
| MACD | -0.02 | -0.02 |
| Stochastic Oscillator | 67.53 | 5.22 |
Orchestra BioMed Holdings Inc is a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships with medical device companies. The company's flagship product candidates are Atrioventricular Interval Modulation Therapy (AVIM Therapy) for the treatment of hypertension, the risk factor for death, and Virtue Sirolimus AngioInfusion Balloon (Virtue SAB) for the treatment of atherosclerotic artery disease, the cause of mortality. It has one reportable segment, which consists of the development of clinical and preclinical product candidates through risk-reward sharing partnerships with medical device companies.
Cohen & Steers Total Return Realty Fund Inc is a diversified closed-end management investment company. Its investment objective is to achieve a high total return through investment in real estate securities. The Fund invests majority of its total assets in the equity securities of real estate companies under normal circumstances, which includes common shares, REITs, rights or warrants, convertible securities, and preferred shares.